Total Funding
78
64
Total FundingSeed raised
Growth Score 78 in past quarter
-7 pts
Heat Score 64 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
23249
Coherence develops healthcare tech linking cancer neuroscience with neurotechnology for new treatments.
- Ben Woodington: CEO and Co-Founder
- Elise Jenkins: Co-Founder and CTO
About the Company
Coherence specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,
Coherence is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector.